| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
2222
|
26.18 | 6,330.9B | 17.31 | 4.27 | 7.75 | 35.1% | 9.8% | 62 | 59 | 24.49 | -4.8% | 95 | 0.23 |
|
2040
|
25.38 | 2.5B | 14.00 | 1.63 | 13.20 | 8.6% | 11.0% | 59 | 40 | 28.20 | +8.0% | 65 | 0.55 |
|
4030
|
35.36 | 32.6B | 12.76 | 2.14 | 8.49 | 9.4% | 9.5% | 56 | 40 | 37.82 | +5.0% | 68 | 0.80 |
|
2030
|
51.00 | 765.0M | — | 2.38 | — | 2.1% | 14.1% | 30 | 21 | 34.01 | -18.7% | 89 | 0.00 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.